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codon83 (Serine83Arginine) was noted in 1 strain having a
CIP MIC of 0.012 and a NA MIC of 32g/ml. All 28 strains
that had a CIP MIC of 0.016—1.5g/ml and frank resis-
tance to NA (MIC ≥16g/ml; DD zone of inhibition ≤13mm)
carried a transversion mutation in codon 83 of gyrA (Ser-
ine83Isoleucine). We noted another transversion mutation in
codon 85 of parC (Serine85Leucine) in 14 of these 28 strains
that had a CIP MIC of ≥0.125—1.5 and a NA MIC ≥256g/ml).
We could not detect any mutations in gyrB (n = 24) and parE
(n = 28) genes.
Conclusion: Reduced CIP-susceptibility and NA-resistance
of V. cholerae is associated with a gyrA mutation (Ser-
ine83Isoleucine). A further decrease in CIP-susceptibility is
associated with parC mutation (Serine85Leucine).
doi:10.1016/j.ijid.2008.05.284
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Prevalance of Extended-Spectrum ˇ-Lactamases pro-
duced by Klebsiella spp. from various clinical samples in
an urban Hospital in South India
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Background:Organisms producing extended-spectrum ˇ-
lactamases(ESBL) are emerging around the world as a source
of resistance to oxyiminocephalosporins such as cefotaxime,
ceftazidime and ceftrioxone.This study was undertaken to
study the prevalence of ESBL production by Klebsiella spp.
in an urban hospital in South India.
Methods:Antimicrobial susceptibility testing of 213
strains of Klebsiella spp. isolated from various clinical speci-
mens was carried out by disc diffusionmethod.One hundered
and ﬁve strains found to be resistant to at least one of
the third generation cepholosporins tested, viz, cefotoxime,
ceftazidime and ceftrioxone were screened for the pro-
duction of ESBL by phenotypic and genotypic methods.The
phenotypic methods include the phenotypic conﬁrmatory
disc diffusion test (PCDDT)and double disc diffusion syn-
ergy test(DDST)and the genotypic method include the PCR
ampliﬁcation method.
Results:Of the 105 strains screened for ESBL producton
45(42.85%)and 43(40.95%) strains were positive by PCDDT
and DDST methods respectively and 53(50.47%)strains were
positive by genotypic method.
Conclusion:The prevalence of ESBL produced by Kleb-
siella spp. from various clinical conditions in this part of the
country is 24.88% as detected by the genotypic method.The
study suggests that ESBL production should be detected rou-
tinely to monitor the resistant organisms for implementation
of appropriate infection control measures.
doi:10.1016/j.ijid.2008.05.285
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Background: Since ﬁrst reported in Germany in 1983
and in the United States in 1989, extended-spectrum ˇ-
lactamases (ESBLs) have spread worldwide. These enzymes
are mostly plasmid-encoded derivatives of TEM-1, TEM-2,
and SHV-1 by one or more base pair changes or are from a
rapidly evolving class called CTX-M.
Methods: K. pneumoniae ML2011 was collected on July
2004, from intensive care unit of Military hospital in Tunisia.
Identiﬁcation of strains was performed by using both API
20 E and the VITEK automated system. Minimal inhibitory
concentrations (MICs) were determined by E-test Strips
for the strain on Mueller-Hinton agar as recommended
by the Clinical and Laboratory Standards Institute (CLSI)
(CLSI/National Committee for Clinical Laboratory Stan-
dards [NCCLS], 2006). Transfer of resistance phenotypes
was performed by transformation and conjugation exper-
iments. The ESBL was identiﬁed by double-disk synergy
test, by isoelectric focusing and sequencing of PCR prod-
ucts.
Results: MICs for K. pneumoniae ML2011 showed
that this strain was resistant to all ˇ-lactams tested
expect imipenem. K. pneumoniae ML20011 exhibited a
high level of resistance to oxyimino cephalosporins.
The strain was also resistant to kanamycin, chloram-
phenicol, ciproﬂoxacin, nalidixic acid, tetracycline and
streptomycin. The disk diffusion method showed synergy
between ceftazidime, cefotaxime, aztreonam, ceftriaxon,
and amoxicillin-clavulanic acid against the strain and its
transformants and transconjugants, suggesting plasmid-
mediated production of an ESBL enzyme. PCR analyses
conﬁrmed the presence of blaSHV in parent strain K. pneu-
moniae ML2011, and its transformants E. coli DH5˛/pML2011
and transconjugants E. coli HB101 X pML2011 indicating
that this gene is located on transferable plasmid with esti-
mated molecular size of 50 kb. Nucleotide sequence was
performed on the coding region 861pb used to predict
the amino acid sequence. This sequence was compared
with strain K. pneumoniae Kp297 (DDBJ/EMBL/GeneBank
accession no. EF035567) for nucleotide sequence homol-
ogy and predicted amino sequence. Two amino acid
substitutions were found at position 5 and 202, result-
ing respectively in a Met (ATG) to Leu (TTG) and an
Arg (CGT) to Ser (AGT) changes. As theses substitu-
tions not showed by other known SHV ˇ-lactamases,
the pI 7.3 from K. pneumoniae ML2011 appears to
be a novel ESBL and has been designated SHV-104
(http://www.lahey.org).
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Conclusion: The modiﬁcation at position 202 may result
in a change of the pI to 7.3 and the extended spectrum of
the enzyme.
doi:10.1016/j.ijid.2008.05.286
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Background: Unlike reports of multidrug-resistant
Salmonella enterica serovar typhi (S. typhi) in countries
around the world, strains encountered in Jamaica have
been uniformly susceptible to all the anti-typhoid drugs
and also to other antibiotics by disc method. We have been
maintaining these isolates on Dorset-egg medium over the
years. In this report, we examine the MICs of 4 front-line
antibiotics against 41 unduplicated isolates(one from a
patient) encountered in consecutive 17 years between 1984
and 2000 at the University Hospital in Kingston, Jamaica.
Methods: The MICs were determined by E test(AB Biodisk,
Solna, Sweden) using E. coli ATCC 25922 as control. Manufac-
turers’ instructions in regard to media, inoculum density and
incubation parameters were followed strictly. Our observa-
tion of extremely low MICs (see results below) made us to
do the tests repeatedly and read the results independently
by each of us (NCB and OH) and repeat again if we differed
in reading by more than one E test dilution.
Results: The MICs(g/ml) of the four antibiotics were
Chloramphenicol MIC range 2—4, MIC50 3 and MIC90 3;
Ampicillin MIC range 0.125—1, MIC50 0.25 and MIC90 0.5;
Trimethprim/Sulpha MIC range 0.023—0.064, MIC50 0.032
and MIC90 0.047; Ceftriaxone MIC range 0.023—0.047, MIC50
0.032 and MIC90 0.047. All isolates were susceptible. MICs
were extremely low, fell in a narrow range and far below
the standard susceptible(CLSI) Breakpoint MICs of the antibi-
otics. We have not seen any report of such a highly
susceptible strains of typhoid bacilli from anywhere in the
world.
Conclusion: Considering the growing increase of
multidrug-resistant typhoid in countries around the world
and reports of isolation of strains with MICs of front-line
antibiotics of more than 256g/ml(Hirose K et al Antimicrob
Ag Chemother 45:956—958,2001), the highly susceptible
nature of strains encountered in Jamaica is noteworthy.
These unique strains which we call ‘Jamaica strains’ have
been persisting in this island country throughout the years.
doi:10.1016/j.ijid.2008.05.287
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Background: Carbapenem-resistant Acinetobacter
spp. have gained increasing signiﬁcance as opportunistic
pathogens in hospitalized patients. Carbapenem resistance
is often associated with the loss and/or decrease in outer
membrane protein and overexpression of multidrug efﬂux
systems. In this study, we describe a study on carbapenem
resistance mechanisms involved in Acinetobacter spp.
isolated from UMMC.
Methods: 39 carbapenem-resistant clinical isolates of
Acinetobacter spp. obtained from inpatients at the Uni-
versity Malaya Medical Centre were used in this study.
Preliminary screening for carbapenemase production was
carried out and IEF was determined in the strains. The iso-
lates were analyzed for the presence of the blaIMP gene
using PCR and conﬁrmed by Southern hybridization to obtain
the location of this gene. Other resistance mechanisms such
the presence of AdeABC efﬂux pump genes were also deter-
mined by PCR followed by inactivation by plasmid insertion
and the resultant mutants were tested for their antimicro-
bial susceptibilities. Presence of outer membrane proteins
were determined by SDS-PAGE. Iron-regulated outer mem-
brane proteins (IROMPs) were expressed under iron deﬁcit
conditions as these are possible targets of antimicrobial
therapy. Thus, antibodies against these IROMPs were raised
and bactericidal activity of the strains was determined.
Results: Out of the 39 strains only two strains, S26 and
S90, both A. calcoaceticus were positive for the presence
of metallo-ˇ-lactamases. Both these strains had similar MIC
values for imipenem, cefotaxime, and aztreonam at 32, 512,
and 64g/ml respectively. IEF analysis showed that both
strains had a band of pI 8.0 which corresponded to that of
blaIMP-4, while an additional band of pI 7.0 was present
in strain S90. Strains, S26 and S90, were PCR positive for
blaIMP, while the remaining 37 harbored blaOXA-23. Ampli-
ﬁcation and subsequent nucleotide sequencing of the entire
coding region of blaIMP conﬁrmed the identity of the blaIMP
amplicon to be blaIMP-4. Plasmid analysis revealed that only
the two strains, S26 and S90, carried plasmids: 147, 63, 36
in both strains with an additional 7 kb plasmid in S26. South-
ern blot hybridization showed that the blaIMP-4 gene was
located on the 36 kb plasmid in strain S26 and was con-
ﬁrmed to be located on Class 1 integron. Screening and
nucleotide sequencing of the Class 1 integron revealed iden-
tical genes: blaIMP4, qacG, aacA4, and catB3 in the 2 strains.
However, PFGE analyses showed that S26 and S90 had dif-
ferent genotypes. Screening of efﬂux pump genes showed
that 36 strains harboured all the 3 genes (adeA, adeB,
and adeC). Inactivation of these individual genes showed
decreased antimicrobial susceptibility indicating its contri-
bution towards the development of antimicrobial resistance.
Besides that, all the strains showed loss of a 27 kDa OMP.
The monoclonal antibodies produced showed bactericidal
effect against the organism tested and it speciﬁcally killed
